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Abstract
Background: Human pigmentation is a polygenic quantitative trait with high heritability. In addition to genetic factors,
it has been shown that pigmentation can be modulated by oestrogens and androgens via up- or down-regulation of
melanin synthesis. Our aim was to identify possible sex differences in pigmentation phenotype as well as in melanoma
association in a melanoma case-control population of Spanish origin.
Methods: Five hundred and ninety-nine females (316 melanoma cases and 283 controls) and 458 males (234 melanoma
cases and 224 controls) were analysed. We genotyped 363 polymorphisms (single nucleotide polymorphisms
(SNPs)) from 65 pigmentation gene regions.
Results: When samples were stratified by sex, we observed more SNPs associated with dark pigmentation and
good sun tolerance in females than in males (107 versus 75; P = 2.32 × 10−6), who were instead associated with
light pigmentation and poor sun tolerance. Furthermore, six SNPs in TYR, SILV/CDK2, GPR143, and F2RL1 showed
strong differences in melanoma risk by sex (P < 0.01).
Conclusions: We demonstrate that these genetic variants are important for pigmentation as well as for melanoma
risk, and also provide suggestive evidence for potential differences in genetic effects by sex.
Keywords: Pigmentation, UV sensitivity, Skin cancer, Sex, Polymorphisms
Background
Human pigmentation traits are some of the most visible
and differentiable human characteristics. Pigmentation in
human tissue is attributable to the number, size and cellu-
lar distribution of melanosomes produced, and the type of
melanin synthesised (the black-brown coloured eumelanin
or the red-yellow coloured phaeomelanin), while the num-
ber of melanocytes is usually unchanged [1].
The type of melanin synthesised is influenced by sun
exposure and is genetically controlled [2]. Ultraviolet
(UV) exposure plays a key role in the evolutionary se-
lective pressure on human pigmentation. Geographic
distribution of human skin pigmentation reflects an
adaptation to latitude-dependent levels of UV radiation
[3, 4]. The linear relationship between worldwide skin
pigmentation variation, latitude, and UV radiation levels is
thought to result from the physiological role of melanin
type in UV-mediated vitamin D synthesis, UV-induced
photolysis of folate, and in the protection from exposure
to UV, which can cause sunburn and skin cancer [5].
However, the physiological role for eye and hair colour
variations still remains unknown.
Variation in genes implicated in human pigmentation
has been associated with phenotypic characteristics such
as skin colour, hair colour, eye colour, freckling, and sen-
sitivity to sunlight [6], and also with the risk of various
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types of skin cancer [7–15]. The proteins encoded by
these genes have effects at various stages of the pigmenta-
tion pathway, ranging from melanogenesis, the stabilisa-
tion and transport of enzymes in the melanin production
pathway, the production and maintenance of melano-
somes and the melanosomal environment, and the switch
between the production of eumelanin and phaeomelanin.
Other pigmentation-related proteins code for intrinsic
factors that help in the regulation of pigmentation, such
as factors produced by fibroblasts in the dermis that
affect overlying melanocytes and keratinocytes, and endo-
crine factors from the blood supply, as well as neural
factors and inflammation-related factors [6, 16, 17].
Melanin synthesis is also modulated, in part, by oestro-
gens and androgens [18]. Physiological hyperpigmentation
in various forms (tanning, dark spots, chloasma, linea
nigra, and/or melasma) is commonly seen in pregnant
females due to an increase of the levels of pregnancy-
related hormones [18]. The increase of pregnancy-related
hormones—oestrogen, progesterone, and melanocyte-
stimulating hormone (α-MSH)—during gestation induces
the activation and expression of genes involved in melanin
synthesis in melanocytes [19], while it has also been
shown that androgens inhibit tyrosinase activity [20]. In
addition to sex-endocrine factors, the use of oestrogen-
containing oral contraceptives, certain cosmetics, and
oestrogen-progesterone therapies has also been associated
with hyperpigmentation [21].
Biological and behavioural gender differences likely
contribute to the sexual disparity in skin aging, pigmen-
tation, and melanoma incidence and outcome [22, 23].
Recent studies point to Caucasian females having slightly
darker eye colour [24, 25] and skin colour [26] than
Caucasian males. Regarding melanoma, females show
lower melanoma predisposition and incidence, lower risk
of metastases, and longer melanoma-specific survival rates
than males [27, 28]. Anatomic location of melanoma in-
deed tends to be different between sexes, being most com-
monly on the lower leg, hip, and thigh in females and on
the back, abdomen, and chest in males [27].
In order to reveal possible sex-related differences in pig-
mentation phenotype as well as in melanoma association,
we investigated the influence of 363 polymorphisms from
65 gene regions—previously associated with pigmentation
traits, congenital pigmentation genetic syndromes, and/or
skin cancer—in a melanoma case-control population of
Spanish origin.
Methods
Study subjects and data collection
In this study, a total number of 599 females (316
melanoma cases and 283 cancer-free controls) and
458 males (234 melanoma cases and 224 cancer-free
controls) were collected at several Spanish hospitals.
We carefully selected all cases and controls included
in the current study to account for confounding vari-
ables. All individuals were Caucasians of Spanish ori-
gin where, according to a previous work by Laayouni
and cols, there is no evidence of genetic heterogeneity
within different Spanish geographical regions [29].
Controls were frequency-matched to the cases by age
and place of birth.
A standardised questionnaire was used to collect in-
formation on sex, age, pigmentation characteristics (eye
colour, hair colour, skin colour, number of naevi, and
presence of solar lentigines), history of childhood sun-
burns, Fitzpatrick’s skin type classification, and personal
and family history of cancer, to classify individuals as
previously described [30]. Forty melanoma cases from
our previous work were excluded in the current ana-
lysis due to the absence of sex details.
All individuals gave written informed consent and
the study was approved by the Ethics Committee of the
Gregorio Marañon Hospital (Madrid, Spain) and the
Biomedical Research Institute - INCLIVA (Valencia, Spain).
Gene, SNP selection, and genotyping
Gene and single nucleotide polymorphism (SNP) selection
was performed as previously described [30]. Sixty-five gene
regions were included in this study. They covered a broad
range of biological processes, mostly related to pigmenta-
tion. We genotyped a total number of 384 tag-SNPs from
the selected genes ranging from the hypothetical promoter
area (approximately 10 kb upstream) until approximately
5 kb downstream of the gene. SNP codes, locations, and
frequencies were obtained from NCBI (www.ncbi.nlm.nih.
gov/SNP), HapMap (www.hapmap.org), and Illumina data-
bases. A minor allele frequency (MAF) threshold of 0.05 in
the HapMap CEU population and an ‘Illumina score’ not
lower than 0.6 (as recommended by manufacturer) were
established to ensure high genotyping success rate of the
SNPs selected.
SNP genotyping was done using the Golden Gate Assay
according to manufacturer’s protocol (Illumina, San Diego,
CA, USA), as previously described [30].
Statistical analysis
Quality control processes and allelic and genotypic asso-
ciation tests were performed using the SNPator software
(www.snpator.com). Additional statistical analyses and
plots were conducted using the R statistical framework.
All genetic analyses were performed estimating the effect
of the minor allele in the Spanish population.
For all polymorphisms studied, Fisher’s exact test was
used both to test for deviations from Hardy-Weinberg
equilibrium (HWE) between sexes and to compare allele
counts between female and male individuals. Bonferroni
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correction was applied and P values higher than
1.37 × 10−4 were considered in HWE.
Associations between the genotyped SNPs and various
pigmentation and sun sensitivity traits were assessed via
logistic regression, coded additively for each copy of the
minor allele. This was done for males and females separ-
ately, with eye colour (blue/green versus brown/black),
hair colour (brown/black versus blond/red), skin colour
(fair versus dark), number of naevi (≥50 versus <50),
presence of lentigines (yes versus no), and childhood sun-
burn (yes versus no) as the outcome variables. Genotype-
related Odds Ratios (ORs), their corresponding 95 %
confidence intervals (CIs) and associated P values were
estimated. Results of the association analysis were rep-
resented using volcano plots, mapping significance
(−log10 P value) versus fold-change (log2 OR) for the
comparison between individuals for eye colour, hair
colour, skin colour, presence of lentigines, childhood
sunburns and naevi number separately. P values were
two sided and those lower than 0.01 were considered
statistically significant (since six pigmentation traits
were studied separately, statistical significant threshold
of P value < 0.05/6 = 0.01).
In order to have an overview of all the significant esti-
mates obtained in the sex-specific logistic regression
analyses, we evaluated the differences in the number of
polymorphisms associated both with protective and risk
phenotypes between sex groups (P values < 0.05), using
2 × 2 contingency tables and performing a Fisher’s
exact test.
Logistic regression was performed to re-assess associa-
tions between genotypes and melanoma risk done previ-
ously [30], but separating individuals by sex in order to
estimate sex-specific ORs, 95 % CIs and P values. As
mentioned above, the minor allele was also modelled
under an additive model. Using the same criteria as in
the analysis of pigmentation traits, two-sided P values
lower than 0.01 were considered to constitute evidence
of association.
Finally, we performed a sex-differentiated regression
estimate test for each SNP for all phenotypic traits. We
tested for equality of sex-specific allelic effects with the
aim of obtaining sex-differentiated P values [31], and a
statistical significance threshold of sex-differentiated
P value < 0.05 was used. Briefly, for each sex-specific as-
sociation test, sex-specific beta coefficients (log ORs)
and the corresponding standard errors were evaluated
using a Chi-square test with one degree of freedom.
Then, a Chi-square test with two degrees of freedom
was performed for each SNP, in which the previously
calculated female-specific and male-specific Chi-square
statistics were added up. Finally, a test of heterogeneity
of allelic effects between males and females using a
Chi-square test with one degree of freedom was
conducted. A significant sex-specific and sex-differentiated
P value is required to verify a potential significance in
allelic effect by sex, following the same criteria used by
Kocarnik and cols. [32]. Manhattan plots were used to
display the strength of significant differences between
male-only and female-only associated effects (−log10
sex-differentiated P value) for each trait tested.
Results and discussion
Our sample set included 599 females and 458 males of
Spanish ancestry. Median age was 45 years (range 18–92)
for females and 47 years (range 18–92) for males. Regard-
ing control individuals, mean age was 42 years (range
18–91) for females and 45 years (range 18–90) for males.
Melanoma cases presented a median age of 52 years
(range 18–92) for females and 53 years (range 18–92) for
males. Since age differences were not observed between
sample subsets (P value > 0.05), association analyses were
not adjusted by age.
From an initial list of 384 tag-SNPs selected, 21 SNPs
(5.4 %) were discarded due to failed genotyping (no PCR
amplification, insufficient intensity for cluster separation
or poor cluster definition). All 363 remaining SNPs were
in HWE after Bonferroni correction (Additional file 1:
Table S1). Minor allele frequencies estimated for each
SNP were almost identical for females and males, with a
remarkable linear correlation (R2) of 0.982 (Additional
file 1: Figure S1).
Association with phenotypic characteristics by sex
In a previous study published by our group, the associ-
ation of some genes with phenotypic characteristics was
reported [30]. However, analyses were performed with-
out taking into account sex data. In the current study,
samples were additionally stratified by sex to evaluate
differences in pigmentation and sun response between
males and females.
Thirty four SNPs showed association with at least one
pigmentation trait, and 42 SNPs were associated with at
least one sun response trait studied (P < 0.01) (Additional
file 1: Tables S2 and S3). Each of these polymorphisms dis-
played a moderate effect on pigmentation in our Spanish
population dataset. Our results showed apparent differ-
ences in the direction of the association with the pigmen-
tation characteristics, with variants showing ORs below
1.0 correlated with dark pigmentation and/or good toler-
ance to sunlight, and variants with ORs above 1.0 associ-
ated with light pigmentation and/or poor tolerance to
sunlight. Variants in these genes most likely play import-
ant roles in the differences in pigmentation and tanning
response among individuals of the Spanish population,
and subsequently also in skin cancer risk [33].
Representations of −log10 P values versus log2 ORs
comparing 599 female individuals to 458 males for eye
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colour, hair colour, skin colour, presence of lentigines,
childhood sunburns and naevi number are shown in Fig. 1.
Detailed information on rs numbers, genes, chromosome
locations, minor alleles, ORs, 95 % CIs, and P values for
pigmentation and sun response characteristics are sum-
marised in Additional file 1: Tables S2 and S3.
Sex-specific analyses in this study showed significant
differences in the pattern of association with pigmenta-
tion and tanning response traits between male and
female individuals. Out of all SNPs with significant
sex-specific associations, we found significantly more
SNPs associated with dark pigmentation or sun pro-
tection in female than in male individuals (107 versus
75; P = 2.32 × 10−6), the latter being more commonly as-
sociated with light pigmentation and poor sun tolerance –
traits highly associated with melanoma predisposition [9]
(Fig. 2). The percentage of SNPs associated with both dark
eye and dark hair colour in females was higher than in
males (72.72 versus 40.74 %, P = 0.025; 78.57 versus
48.28 %, P = 0.018, respectively). This association pattern
was also observed for skin colour, but without signifi-
cance (66.67 versus 41.94 %, P = 0.068). In addition,
female individuals presented more SNPs associated
with both ≤50 naevi and absence of childhood sun-
burns than males (65.38 versus 36.67, P = 0.032; 61.11
versus 36.11 %, P = 0.034; respectively). On the other
hand, a similar percentage of SNPs associated with
absence of lentigines was observed in both female
and male individuals (56.00 versus 43.33 %, P = 0.35).
A representation of the distribution/count of poly-
morphisms associated with phenotype groups for each
trait studied, separated by sex, is displayed in Fig. 2.
It is important to note that these associations do not
reflect differences in the allelic frequencies of these pig-
mentation genes between males and females. These re-
sults basically indicate that, for a given genotype, the
allelic effects on the phenotypic traits are shown to be
significantly different in both sexes.
Additionally, sex-differentiated analysis was performed
in order to test for equality between male-specific and
female-specific regression estimates. Sex-differentiated
P values are represented in Fig. 3. A significant sex-specific
and sex-differentiated SNP association is required to estab-
lish a potential difference in effect for each polymorphism
Fig. 1 Volcano plots showing significance (−log10 P value) versus fold change (log2 OR) for pigmentation and sun sensitivity traits separated by
sex. Red dots indicate SNPs with a significant fold change (P values < 0.01)
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by sex. Three SNPs showed a strong potential sex-
difference in eye colour effect, 10 SNPs in skin colour
effect, 3 SNPs in hair colour effect, 4 SNPs in sunburns
effect, 5 SNPs in lentigines effect, and 5 SNPs in naevi effect
(P < 0.01). Among these SNPs, PLDN SNP rs12909221,
GPR143 SNP rs2521667, POMC SNP rs6734859, AP3M2
SNP rs7009632, BCL2 SNP rs1462129, and TYRP1 SNP
rs10809828 were associated with light pigmentation and
poor sun tolerance in males. Only one polymorphism,
rs2521578 on the GPR143 gene, showed a high association
with poor sun tolerance in females (Additional file 1:
Tables S2 and S3).
Promising differences in allelic effect by sex were also
observed for TYR SNP rs1042602. Females and males
showed statistically significant effects in opposite direc-
tions for this SNP, and this difference in effect by sex
would remain hard to discriminate from chance. Indeed,
a sex-differentiated P value of 1.30 × 10−3 was estimated
for rs1042602, as shown in Fig. 3.
Polymorphisms showing potential differences in allelic
effect by sex are located on genes that have functions re-
lated to melanocyte development, melanosome formation,
maturation, and transportation, as well as to skin cancer
[6, 9, 10, 15, 16, 30, 34–37]. Interestingly, we also found
Fig. 2 Distribution of the SNPs associated with pigmentation and sun sensitivity traits separated by sex. The percentage of each phenotype
(protection or risk) is calculated taking into account the total number of significant SNPs associated in males and females (P values < 0.05).
Percentages are represented by bars of the corresponding colour. The number on the top of each bar represents the count of associated SNPs
in each category
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associations between pigmentation phenotypes and several
genes—CDKN2A, GNA11, NRAS, and WNT3A—involved
in the up-regulation of melanogenic genes, the activation,
survival, and proliferation of the melanocyte, and/or the
processes leading to carcinogenesis.
Associations with melanoma risk by sex
In a previous study published by our group, the associ-
ation of 65 gene regions with melanoma risk was re-
ported [30]. However, at that time, no sex stratification
was applied to perform the association analysis. In this
work, we have carried out an analysis of association be-
tween genotypes and melanoma risk for female and male
individuals separately.
Sixteen SNPs located in 10 genes showed consistent
male- or female-specific association with melanoma risk.
Eleven of those SNPs showed potential differences in effect
by sex, since P values obtained in the sex-differentiated re-
gression estimate test were lower than 0.05. Detailed infor-
mation on rs numbers, genes, chromosome locations,
Fig. 3 Manhattan plots displaying the strength of significant differences between male-only and female-only associated effects (−log10 sex-differentiated
P value) for a) pigmentation and b) sun sensitivity traits. Darker dots of the corresponding colour indicate SNPs with a significant fold change (sex-differentiated
P values < 0.01)
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minor alleles, ORs, 95 % CIs, and P values for melanoma
risk are summarised in Table 1.
Among these 11 SNPs, we found six SNPs located in 4
genes showing a strong difference in melanoma risk ef-
fect when samples were stratified by sex – sex-specific
and sex-differentiated P values lower than 0.01. F2RL1
SNP rs2242991, GPR143 SNPs rs2521667, and rs2732872,
and TYR SNP rs5021654 increased melanoma predis-
position in males as opposed to females. Additionally, a
strong melanoma protective effect was displayed by
rs2069398 on CDK2/SILV in females only. These SNPs
were also associated with pigmentation and sun toler-
ance in opposite directions in males (ORs > 1, melanoma
risk traits) versus females (ORs < 1, melanoma protective
traits), supporting lower melanoma predisposition and in-
cidence in females than in males. Oppositely, rs1042602
on the TYR gene showed a melanoma protective effect in
males compared to females. Therefore, these results are in
accordance with the association between rs1042602 and
dark pigmentation and good sun tolerance in males but
not in females (Additional file 1: Tables S2 and S3).
These genes with potential differences in melanoma
risk effect by sex are graphically represented in Additional
file 1: Figure S2. The F2RL1/PAR2 gene, expressed in ker-
atinocytes but not in melanocytes, is a G-protein coupled
receptor involved in melanosome transfer [38], and
changes in its expression pattern are correlated with skin
cancer progression [39]. The GPR143 gene, located in the
X chromosome, encodes for a G-protein coupled recep-
tor for tyrosine, L-DOPA, and dopamine localised on
melanosomal membranes and plays an important role
in melanosome biogenesis, organisation and transport.
Ocular albinism type 1 (OA1; MIM300500) is caused
by mutations in GPR143 and is transmitted as an X-
linked trait. The TYR gene codes for another melanoso-
mal membrane-bound enzyme involved in the rate-
limiting steps of melanogenesis. Mutations in the TYR
gene are associated with light pigmentation, freckling
and sun sensitivity—well-recognised melanoma risk fac-
tors—as well as with melanoma [30, 40]. The CDK2 gene,
which overlaps with the melanocyte-specific gene SILV, is
also important for melanoma growth and proliferation
[41]. SILV melanosomal matrix protein represents a
melanoma-specific antigen recognised by tumour infiltrat-
ing cytotoxic T lymphocytes [42].
A recent study is worth mentioning in this respect.
According to Kocarnik and cols. (2014), SLC45A2 SNP
rs16891982, the non-synonymous mutation F374L lo-
cated in exon 5, influenced melanoma risk differently by
sex, with higher melanoma risk for males than females,
probably through alterations in melanogenesis and pig-
mentation [32]. In our study, two SNPs on the SLC45A2
gene (rs35414 and rs35415) displayed associations with
melanoma in both female-only and male-only ana-
lysis, although they do not present significant sex-
differentiated P values. It is important to note that
Table 1 SNPs highly associated with melanoma risk in sex-stratified analysis
Melanoma
Female Male Sex-diff
Gene SNP ID Chr mA P value OR P value OR P value
AP3B1 rs11742673 5 A 0.0020 1.43 (1.14–1.80) 0.88 0.98 (0.75–1.28) 0.0210
CDK2/SILV rs2069398 12 A 3.03E−4 0.47 (0.31–0.71) 0.06 0.60 (0.35–1.03) 0.0016
F2RL1 rs2242991 5 G 0.56 0.92 (0.68–1.22) 0.0076 1.61 (1.13–2.29) 0.0067
GPR143 rs2521667 X G 0.46 0.89 (0.67–1.20) 7.04E−4 1.89 (1.30–2.74) 7.85E−4
rs2732872 X C 0.78 0.96 (0.73–1.27) 8.43E−4 1.81 (1.27–2.57) 0.0052
KIT rs6554198 4 G 0.46 0.92 (0.73–1.15) 0.0027 0.67 (0.51–0.87) 0.07
MYO7A rs3758708 11 A 0.20 1.30 (0.87–1.95) 4.12E−4 2.38 (1.46–3.90) 0.0480
RAB38 rs524121 11 C 0.0086 0.51 (0.30–0.85) 0.36 1.32 (0.73–2.38) 0.0210
RGS20 rs6981243 8 C 0.38 0.90 (0.71–1.14) 0.0021 0.66 (0.51–0.86) 0.0490
SLC45A2 rs35414 5 T 0.03 0.77 (0.61–0.97) 0.0018 0.66 (0.51–0.85) 0.39
rs35415 5 A 0.03 0.78 (0.62–0.97) 0.0080 0.70 (0.54–0.91) 0.35
TYR rs1042602 11 A 0.35 1.11 (0.89–1.40) 0.0047 0.68 (0.53–0.89) 0.0081
rs12270717 11 C 0.60 1.07 (0.82–1.40) 0.0032 1.56 (1.16–2.09) 0.09
rs17793678 11 T 0.32 1.14 (0.88–1.49) 0.0036 1.55 (1.15–2.08) 0.26
rs2186640 11 G 0.39 0.90 (0.71–1.15) 9.20E−4 1.57 (1.20–2.05) 0.0380
rs5021654 11 C 0.47 0.92 (0.72–1.16) 2.03E−4 1.66 (1.27–2.17) 0.0014
Entries in italics indicate statistically significant results
SNP single nucleotide polymorphism, Chr chromosome, mA minor allele, OR odds ratio per minor allele, CI confidence interval, Sex-diff sex-differentiated
meta-regression estimate test
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the minor allele of these two SNPs showed a protect-
ive effect for melanoma and that the allele frequencies
for these protective minor alleles, causing a darker
pigmentation, are actually quite common in the Span-
ish population, as opposed to Northern European
populations. Subsequently, this association was stron-
ger in males (rs35414: OR = 0.66, 95 % CI 0.51–0.85,
P = 0.0018; and rs35415: OR = 0.70, 95 % CI 0.54–
0.91, P = 0.008) than in females (rs35414: OR = 0.77,
95 % CI 0.61–0.97, P = 0.026; and rs35415: OR = 0.78,
95 % CI 0.62–0.97, P = 0.029). In the male-only but
not in the female-only analysis, rs35414 and rs35415
tended to be also associated with dark pigmentation
and the absence of childhood sunburns (P < 0.05). It is
important to state here that in the work by Kocarnik
and cols., it was the major allele—in the Caucasian
population—of the SLC45A2 SNP that was in fact
modelled as the purposed risk allele for melanoma,
while in this study it is the minor allele of the two
SLC45A2 SNPs that was actually used as reference to
perform the analyses. Therefore, the genetic effect
shown by the SLC45A2 gene in our study exhibits the
opposite direction that the one displayed by the
Kocarnik and cols. work.
We are aware of the limitations of the current work.
Firstly, the sample size was relatively restricted after div-
iding by sex the complete sample set, probably resulting
in limited statistical power to detect modest effects for
additional SNPs. Unfortunately, there are not previously
published genome-wide studies presenting data stratified
by sex, hindering chances of enlarging the sample size.
Secondly, the subjective nature of the attributes consid-
ered may be another reason for misclassification. Thirdly,
we presented two-sided unadjusted P values for the asso-
ciations considered; and the level of statistical significance
considered was lower than the threshold required to
declare unequivocally positive results. However, the
results of this work—as well as other previous studies
[24, 25, 32]—show that there is a strong tendency
showing sex-differentiated genetic effects in pigmen-
tary traits. Therefore, we believe that the work pre-
sented here is nonetheless reporting very interesting
findings. For all these limitations, replication of our
findings is essential before venturing on drawing firmer
conclusions.
The results of this study suggest that there are indeed
sex-specific genetic effects in human pigmentation, with
larger effects for darker pigmentation in females com-
pared to males. A plausible cause might be the differen-
tially expressed melanogenic genes in females due to
higher oestrogen levels. These sex-specific genetic effects
would help explain the presence of darker eye and skin
pigmentation in females, as well as the well-known higher
melanoma risk displayed by males.
Conclusions
Overall, the results of this work reveal the presence of
sex-specific effects in human pigmentation that might be
important not only in skin colour and sensitivity to sun-
light but also in the higher incidence of melanoma de-
scribed in males. These findings also show that, at times,
sex-stratified analyses enrich genetic association studies
with valuable information and knowledge.
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